The STOP-HPV Trial 3: Prompts Intervention

Status Active, not recruiting

Clinical Trial Summary

Most adolescents who receive human papillomavirus (HPV) vaccine are vaccinated in pediatric practices, yet missed opportunities (MOs) for HPV vaccination occur often and lead to low HPV vaccination rates. This study is part of a series of cluster randomized clinical trials (RCTs) that will test the effectiveness (and cost-effectiveness) of the addition of prompts (period 3) to performance feedback (period 2, continued through period 3) and training providers previously received on HPV vaccine communication (period 1) to reduce MOs and increase HPV vaccination rates.

Clinical Trial Description

This intervention will incorporate prompts via electronic health record (EHR) (e.g. alerts in electronic charts indicating patient is due for vaccination) and study practice staff prompts (reminders from study staff that a patient is due for vaccination, e.g. placing Vaccine Information Statements (VISs) on desk) to study practitioners that encourage HPV vaccination at all visits. An initial learning module on practitioner prompts will highlight how study practices can consistently implement both EHR and staff HPV vaccination prompts at all visits. Throughout the intervention, text message mini-lessons will remind participants how to best use prompts via EHR and/or office staff to improve HPV vaccination rates. This trial focuses on study period 3 where study periods are as follows: Period 0: Baseline period, prior to the randomization of practices into intervention arms Period 1: Arm-1 intervention study practices receive communication skills training; Arm-2 comparison study practices provide standard of care. Period 2: Arm-1 intervention study practices add performance feedback, building upon their prior training in communication skills; Arm-2 comparison study practices continue delivering standard of care. Period 3: Arm-1 intervention study practices add prompts, building upon prior communication skills and performance feedback; Arm-2 comparison study practices continue with standard of care. Due to the COVID-19 pandemic, an additional 15-month study period (Pause Period) was introduced between feedback (Period 2) and prompts (Period 3). No study activities were undertaken during this time. The prompts intervention effect will be interpreted within the context of the previous periods (Periods 0, 1 and 2) and the pause period. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03599583
Study type	Interventional
Source	University of California, Los Angeles
Contact
Status	Active, not recruiting
Phase	N/A
Start date	August 7, 2018
Completion date	July 15, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05009251` - Using Explainable AI Risk Predictions to Nudge Influenza Vaccine Uptake	N/A
Completed	`NCT03284515` - Vaccination In Pregnancy Gene Signature: VIP Signature Study
Completed	`NCT05012163` - Lottery Incentive Nudges to Increase Influenza Vaccinations	N/A
Recruiting	`NCT05996549` - Cost-effectiveness of the Influenza Vaccination	Phase 4
Completed	`NCT04323137` - Encouraging Flu Vaccination Among High-Risk Patients Identified by ML	N/A
Completed	`NCT01224301` - School Influenza Vaccine vs Standard of Care With Nested Trial of 2 Parent Notification Intensities	N/A
Completed	`NCT00169858` - Long Term Immunogenicity Study of Engerix-B Vaccine in 10 Year Old Children and the Effect of Booster Injections	Phase 4
Completed	`NCT05509283` - Nudging Flu Vaccination in Patients at Moderately High Risk for Flu and Flu-related Complications	N/A
Completed	`NCT02907580` - Influenza Vaccine Attitudes, Intent, and Receipt: Pediatric	N/A
Recruiting	`NCT06160999` - Improving Uptake of Pediatric Vaccines Through Religious Conferences and Vaccines-in-a-van in Aceh, Indonesia	N/A
Recruiting	`NCT03875703` - Post-Vaccination Biological Collection
Completed	`NCT03287830` - Flu2Text: Text Message Reminders for 2nd Dose of Influenza Vaccine	N/A
Completed	`NCT02907645` - Influenza Vaccine Randomized Educational Trial: Adult	N/A
Completed	`NCT03220555` - Efficacy of the Buzzy® Device on the Prevention of Health Care Induced Pediatric Pain in a Vaccination Center	N/A
Withdrawn	`NCT05023512` - Understanding Public Attitudes Towards the COVID-19 Vaccination	N/A
Recruiting	`NCT02937428` - To Look or Not to Look at the Needle During Vaccination	Phase 3
Completed	`NCT00813319` - Girls OnGuard: HPV Vaccination Uptake Among African American Adolescent Females	Phase 3
Completed	`NCT03104790` - Assessment of Viral Shedding in Children Previously in Receipt of Multiple Doses of Live Attenuated Influenza Vaccine (LAIV) Compared to Influenza Vaccine-naïve Controls	Phase 4
Completed	`NCT04780867` - Psychological and Lifestyle Factors on Health Outcomes	N/A
Completed	`NCT03239795` - Promoting Influenza Vaccination In General Practice Waiting Rooms	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

The STOP-HPV Trial 3: Prompts Intervention — STOP-HPV

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms